期刊文献+

胺碘酮治疗西宁地区47例器质性心脏病人室性心律失常的疗效和安全性分析 被引量:1

原文传递
导出
摘要 目的:评价胺碘酮治疗中度高原地区(西宁,海拔2 260m)器质性心脏病人室性心律失常的疗效和安全性.方法:观察47例中度高原地区器质性心脏病人采用胺碘酮治疗室性心律失常的疗效和安全性,随访(1~3)年.结果:6例反复发作的持续性室速、室颤病人,首剂(3~5)mg/kg胺碘酮10min内静脉注射,再以(1~1.5)mg/min缓慢滴注,室速均被有效终止.以200mg/d胺碘作为长期维持量能有效的控制室性早搏(92.7%).6例静脉注射胺碘酮病人中窦性心动过缓5例、PR间期延长1例;在41例长期口服维持量的病人中甲状腺功能低下者1例、窦性心动过缓18例、QT间期延长22例,但无肺损害发生.结论:采用胺碘酮治疗中度高原地区器质性心脏病人室性心律失常效果满意,安全可靠.
作者 陈惠新
出处 《高原医学杂志》 CAS 2006年第3期30-32,共3页 Journal of High Altitude Medicine
  • 相关文献

参考文献10

  • 1CIBIS-Ⅱ Invstigators and commitlees.The Cardiax insaiticiency bisoprolol study Ⅱ(CIBIS-Ⅱ);a randomized trial.Lancet,1999,353(9146);9~13.
  • 2Amiodarone Trials Meta-Analysis Investigators.Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure:MetaAnalysis of individual data from 6500 patients in randomized trials.Lancet,1997,350:1417~1424.
  • 3袁贤奇,宋有城,朱俊,王国干,贺丽霞,谭慧琼,杨艳敏,康连鸣,郝云霞.大剂量胺碘酮静脉注射在顽固性室性心动过速、心室颤动中的临床应用[J].中国心脏起搏与心电生理杂志,2001,15(5):295-297. 被引量:33
  • 4赵长林,陈璘,刘金来,关健强.胺碘酮长疗程个体化治疗室性心律失常的临床疗效和安全性[J].中国心脏起搏与心电生理杂志,2001,15(5):313-314. 被引量:13
  • 5Boutitie F,Boissel JP,Connolly SJ,et al.Amiodarone interaction with beta-blockers; anslysis of the merged EMIAT(European.Myocardial Infarct Amiodarone Trial) and CAMIAT(Camadoam Amiodarone Myocardial Infarction Trial) datatases.The EMIAT and CAMIAT Investigators.Circulation,1999,99(17):2268~2275.
  • 6GuIdelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care.Part 6:advanced cardiovascular life support.Section 1:introduction to ACLS from the Guidelines 2000 Conference.Circulation,2001,102 (Suppl1):186~189.
  • 7Ryan TJ,Antman Em,Brooks NH,et al.1999 update;ACC/AHA guidelines for the management of patients with acutemyocardial infarction; executive summary and recommendation:a report of the American college of Cardiology/American heart association task force on practive guidelines (committee on management of acute myocardial Infarction).Circulation,1999,100(9):1016~1030.
  • 8陈再嘉 高润霖.冠心病[M].北京:人民卫生出版社,2002.942-943.
  • 9陈灏珠.内科学,4版.北京:人民卫生出版社,1996,162:272—273
  • 10刘世明.中度高原地区胺碘酮血药浓度的临床监测及意义[J].高原医学杂志,2004,14(1):46-47. 被引量:2

二级参考文献12

  • 1[1]Cairns JA. Randomised trial of outcome after myocardialInfarction in pa tients with frequent or repetitive ventricular premature depolarisation:CAMIAT [J]. Lancet, 1997,349:675
  • 2[2]Singh SN. Amiodarone in patients with congestive heart failure and symp tomatic ventricular arrythmia[J]. N Engl J Med, 1995,33:77
  • 3[3]Chuang CL, Chem MS, Chang SC, et al. Amiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland, and lung[ J]. Am J Med Sci,2000,320(1) :64
  • 4[4]Loh KC. Amiodarone-induced thyroid disorders: a clinical review[J]. Postgrad Med J,2000,76(893): 133
  • 5Jandreski MA.Clinical measurement of serum amiodarone and desethylamiodarone by using solid phase extraction followed by HPLC with a high-carbon reversed-phase column. Clin Chem,1993,39:496.
  • 6Holt DW, Tucker GT, Jackson PR, et al. Amiodarone pharmacokinetics. Ibib,1983,106:951-956.
  • 7李发美.医用高效液相色谱技术[M].北京:人民卫生出版社,1999..
  • 8袁贤奇,宋有城,朱俊,杨艳敏,郝云霞.静脉注射胺碘酮治疗顽固室速和室颤疗效研究[J]中国急救医学,2000(10).
  • 9杨艳敏,宋有城,朱俊,袁贤奇,谭慧琼,贺丽霞,章友华,章晏,李建东,曹辉.大剂量静脉用胺碘酮治疗顽固性、持续性室性心律失常的临床疗效及安全性[J].中国循环杂志,1998,13(1):20-22. 被引量:78
  • 10张丽琨,陈辉,张柱国.胺碘酮大剂量静脉应用治疗急性心肌梗死后恶性室性心律失常[J].国外医学(心血管疾病分册),1999,26(3):163-164. 被引量:22

共引文献47

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部